{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:58:45Z","timestamp":1770490725619,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10787-020-00755-x","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T18:02:47Z","timestamp":1599933767000},"page":"1477-1480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-6025","authenticated-orcid":false,"given":"Mina T.","family":"Kelleni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"755_CR1","unstructured":"American College of Cardiology (2020) HFSA\/ACC\/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19. from https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/03\/17\/08\/59\/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19. Accessed\u00a017 Mar 2020"},{"key":"755_CR2","doi-asserted-by":"publisher","first-page":"117905","DOI":"10.1016\/j.lfs.2020.117905","volume":"256","author":"N Banu","year":"2020","unstructured":"Banu N, Panikar SS, Leal LR, Leal AR (2020) Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: therapeutic implications. Life Sci 256:117905","journal-title":"Life Sci"},{"key":"755_CR3","doi-asserted-by":"crossref","unstructured":"Bean D, Kraljevic Z, Searle T, Bendayan R, Pickles A, Folarin A, Roguski L, Noor K, Shek A, Gallagher K, Zakeri R, Shah A, Teo J, Dobson RJB (2020) Treatment with ACE-inhibitors is associated with less severe disease with SARS-COVID-19 infection in a multi-site UK acute Hospital Trust. medRxiv: 2020.2004.2007.20056788","DOI":"10.1101\/2020.04.07.20056788"},{"key":"755_CR4","doi-asserted-by":"crossref","unstructured":"Brown JD (2020) Antihypertensive drugs and risk of COVID-19? The Lancet Respir Med 8(5):e28.","DOI":"10.1016\/S2213-2600(20)30158-2"},{"key":"755_CR5","first-page":"E008","volume":"48","author":"C Chen","year":"2020","unstructured":"Chen C, Chen C, Yan JT, Zhou N, Zhao JP, Wang DW (2020) Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi 48:E008","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"755_CR6","doi-asserted-by":"crossref","unstructured":"Deng SQ, Peng HJ (2020) Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med 9(2)","DOI":"10.3390\/jcm9020575"},{"issue":"3","key":"755_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","volume":"53","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain J-M, Raoult D (2020) ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect 53(3):425\u2013435","journal-title":"J Microbiol Immunol Infect"},{"key":"755_CR8","unstructured":"European Medicines Agency (2020) EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic. from.\u00a0https:\/\/ern-euro-nmd.eu\/ema-advises-continued-use-of-medicines-for-hypertension-heart-or-kidney-disease-during-covid-19-pandemic\/. Accessed 31 Mar 2020"},{"issue":"5","key":"755_CR9","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/S2213-2600(20)30159-4","volume":"8","author":"L Fang","year":"2013","unstructured":"Fang L, Karakiulakis G, Roth M (2013) Antihypertensive drugs and risk of COVID-19? Authors' reply. Lancet Respir Med 8(5):e32\u2013e33","journal-title":"Lancet Respir Med"},{"issue":"4","key":"755_CR10","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21","journal-title":"Lancet Respir Med"},{"issue":"2","key":"755_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jama.2020.11301","volume":"324","author":"EL Fosb\u00f8l","year":"2020","unstructured":"Fosb\u00f8l EL, Butt JH, \u00d8stergaard L, Andersson C, Selmer C, Kragholm K, Schou M, Phelps M, Gislason GH, Gerds TA, Torp-Pedersen C, K\u00f8ber L (2020) Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. JAMA 324(2):168\u2013177","journal-title":"JAMA"},{"key":"755_CR12","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche,A Muller MA, Drosten C, Pohlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell","DOI":"10.1016\/j.cell.2020.02.052"},{"issue":"4","key":"755_CR13","first-page":"297","volume":"6","author":"M Kelleni","year":"2018","unstructured":"Kelleni M (2018) Drug induced malignancy: a focus on pioglitazone. Pharm Pharmacol Int J 6(4):297\u2013299","journal-title":"Pharm Pharmacol Int J"},{"key":"755_CR14","doi-asserted-by":"crossref","unstructured":"Kelleni M (2020a) Ibuprofen potential addition to COVID-19 early management protocols: could it be superior to paracetamol and hydroxychloroquine? Authorea, from https:\/\/journal.sketchingscience.org\/users\/318758\/articles\/448656-ibuprofen-potential-addition-to-covid-19-early-management-protocols-could-it-be-superior-to-paracetamol-and-hydroxychloroquine. Accessed 6 May 2020","DOI":"10.22541\/au.158878847.71450719"},{"key":"755_CR15","unstructured":"Kelleni M (2020b) ACEIs, ARBs, ibuprofen linked to COVID-19: the other side of the broken mirror. Authorea, from https:\/\/www.authorea.com\/users\/318758\/articles\/456017-aceis-arbs-ibuprofen-linked-to-covid-19-the-other-side-of-the-broken-mirror?commit=c85d790e9c1c2a3e698675ed1798efe534abdfa7. Accessed 2 Jun 2020"},{"key":"755_CR16","unstructured":"Kelleni M (2020c) Breakthrough: Ibuprofen\/nitazoxanide\/azithromycin: a battle changer personalized COVID-19 telemedicine five days protocol. Authorea from https:\/\/www.authorea.com\/users\/318758\/articles\/460853-breakthrough-ibuprofen-nitazoxanide-azithromycin-a-battle-changer-personalized-covid-19-telemedicine-five-days-protocol?commit=52337e49b98b96fae21dab166828780e5f544a80. Accessed 22 Jun 2020"},{"issue":"4","key":"755_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1440-1681.2008.04889.x","volume":"35","author":"A Koitka","year":"2008","unstructured":"Koitka A, Cooper ME, Thomas MC, Tikellis C (2008) Angiotensin converting enzyme 2 in the kidney. Clin Exp Pharmacol Physiol 35(4):420\u2013425","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"755_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med 11(8):875\u2013879","journal-title":"Nat Med"},{"issue":"Pt A","key":"755_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","volume":"125","author":"XC Li","year":"2017","unstructured":"Li XC, Zhang J, Zhuo JL (2017) The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res 125(Pt A):21\u201338","journal-title":"Pharmacol Res"},{"issue":"7","key":"755_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40264-020-00953-0","volume":"43","author":"N Moore","year":"2020","unstructured":"Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C (2020) Does ibuprofen worsen COVID-19? Drug Saf 43(7):611\u2013614","journal-title":"Drug Saf"},{"issue":"7","key":"755_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","volume":"39","author":"GY Oudit","year":"2009","unstructured":"Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 39(7):618\u2013625","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"755_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000375362","volume":"131","author":"W Qiao","year":"2015","unstructured":"Qiao W, Wang C, Chen B, Zhang F, Liu Y, Lu Q, Guo H, Yan C, Sun H, Hu G, Yin X (2015) Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology 131(2):97\u2013106","journal-title":"Cardiology"},{"issue":"9","key":"755_CR23","doi-asserted-by":"publisher","first-page":"1259.e5","DOI":"10.1016\/j.cmi.2020.06.003","volume":"26","author":"E Rinott","year":"2020","unstructured":"Rinott E, Kozer E, Shapira Y, Bar-Haim A, Youngster I (2020) Ibuprofen use and clinical outcomes in COVID-19 patients. Clin Microbiol Infect 26(9):1259.e5\u2013e7","journal-title":"Clin Microbiol Infect"},{"key":"755_CR24","doi-asserted-by":"crossref","unstructured":"Smart L, Fawkes N, Goggin P, Pennick G, Rainsford KD, Charlesworth B, Shah N (2020) A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality. Inflammopharmacology","DOI":"10.1007\/s10787-020-00745-z"},{"key":"755_CR25","unstructured":"The Local (2020) UPDATE\u2014Coronavirus: French health minister and WHO issue warning over taking anti-inflammatories. From https:\/\/www.thelocal.fr\/20200314\/coronavirus-french-health-minister-issues-warning-over-anti-flammatories. Accessed 14 Mar 2020"},{"key":"755_CR26","unstructured":"University of Basel (2020) Ibuprofen and COVID-19. From https:\/\/www.unibas.ch\/en\/News-Events\/News\/Uni-Research\/Ibuprofen-and-COVID-19-Setting-the-record-straight.html. Accessed 16 Mar 2020"},{"issue":"17","key":"755_CR27","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with COVID-19. N Engl J Med 382(17):1653\u20131659","journal-title":"N Engl J Med"},{"issue":"5","key":"755_CR28","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/en.2006-1287","volume":"148","author":"S Wakahara","year":"2007","unstructured":"Wakahara S, Konoshita T, Mizuno S, Motomura M, Aoyama C, Makino Y, Kato N, Koni I, Miyamori I (2007) Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio. Endocrinology 148(5):2453\u20132457","journal-title":"Endocrinology"},{"key":"755_CR29","doi-asserted-by":"crossref","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol JVI.00127-00120","DOI":"10.1128\/JVI.00127-20"},{"key":"755_CR30","doi-asserted-by":"publisher","first-page":"107628","DOI":"10.1016\/j.pharmthera.2020.107628","volume":"215","author":"JJ Wang","year":"2020","unstructured":"Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C (2020) Good or bad: application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacol Ther 215:107628","journal-title":"Pharmacol Ther"},{"key":"755_CR31","unstructured":"WHO (2020) Q: could ibuprofen worsen disease for people with COVID-19? From https:\/\/twitter.com\/WHO\/status\/1240409217997189128. Accessed 19 Mar 2020"},{"issue":"2","key":"755_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","volume":"171","author":"DW Wong","year":"2007","unstructured":"Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171(2):438\u2013451","journal-title":"Am J Pathol"},{"key":"755_CR33","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/all.14238","volume":"75","author":"JJ Zhang","year":"2020","unstructured":"Zhang JJ, Dong D, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD (2020) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 75:1730\u20131741","journal-title":"Allergy"},{"issue":"7798","key":"755_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00755-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-020-00755-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00755-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:11:40Z","timestamp":1631405500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-020-00755-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1007\/s10787-020-00755-x","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"5 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}